A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

NCT01876550 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1902

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondarily Infected Traumatic Skin Lesions

Interventions

DRUG: Mupirocin Calcium Cream, 2%
DRUG: Bactroban® Cream
DRUG: Cream vehicle of test product

Sponsor

Sun Pharmaceutical Industries, Inc.